• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    New research teams funded in pancreatic cancer, glioblastoma

    New research teams funded in pancreatic cancer, glioblastoma

    Dana-Farber/Harvard Cancer Center and the David H

    New awards promote collaboration in womenís cancers research

    Dana-Farber/Harvard Cancer Center has announced its first round of funding through the Menís Collaborative to Cure Womenís Cancers, an unprecedented partnership providing a vehicle for men to support cutting edge research in breast and gynecologic cancers across the DF/HCC community

    Cancer Cell Biology Program: Matchmaker to Interdisciplinary Researchers

    Conquering cancer is too daunting for any one discipline, approach, or individual

    Translating disease-related findings

    While John Blenis, PhD (HMS), a cell biologist and biochemist interested in cancer cell metabolism, works at the basic science level, he collaborates with pre-clinical researchers

    Cell Manipulation Core Facility

    The Cell Manipulation Core Facility (CMCF) produces safe and effective cellular components for subjects enrolled in novel therapeutic clinical research protocols

    Eleven new members join DF/HCC

    Eleven individuals have recently joined DF/HCC

    DF/HCC-led trials aim to overcome resistance in metastatic GIST

    Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the gastrointestinal tract

Displaying results 71 to 77 out of 229